News
- 2023.03.22 UnicoCell Receives US FDA Approval to Conduct Phase III Clinical Trial for Knee Osteoarthritis Treatment
- 2023.2.8 UnicoCell has been granted approval for phase III clinical trial for the treatment of knee osteoarthritis
- 2022.12.26 UnicoCell received Acknowledgment letter of DMF (Drug Master File) from US FDA for its allogeneic cell bank
- 2022.12.3 UnicoVial was granted the winner at the National Innovation Award Ceremony
- 2022.12.1- 12.4 Visit UnicoCell @2022 Healthcare+ Expo Taiwan
- 2022.11.9 UnicoVial has won the 19th National Innovation Award held by Institute for Biotechnology and Medicine Industry
Products & services
